Cefotaxime
CEFOTAXIME FOR INJECTION, USP
Approved
Approval ID
ed23b6bc-32c7-4c50-a53d-313ae78e5623
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 25, 2021
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 001230762
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefotaxime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9930
Application NumberANDA065072
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefotaxime
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 25, 2021
FDA Product Classification
INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Quantity: 500 mg in 1 1
Code: 258J72S7TZ
Classification: ACTIM
Cefotaxime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9931
Application NumberANDA065072
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefotaxime
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 25, 2021
FDA Product Classification
INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Quantity: 1 g in 1 1
Code: 258J72S7TZ
Classification: ACTIM
Cefotaxime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9933
Application NumberANDA065072
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefotaxime
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 25, 2021
FDA Product Classification
INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Quantity: 2 g in 1 1
Code: 258J72S7TZ
Classification: ACTIM